What are the key Intellectual Property (IP) essentials for drug discovery startups?

In the high-stake world of drug discovery, intellectual property (IP) is a strategic asset that can make or break a company’s future.

For startups pushing the boundaries of science and technology, navigating the complex IP landscape is both a challenge and an opportunity. We have prepared a series of articles exploring the critical IP issues facing early-stage innovators in drug discovery and offers actionable strategies to help protect breakthroughs, attract investment, and build long-term value.

Published in the lead-up to ELRIG Drug Discovery 2026, this series is designed to equip you with the insights you need to approach IP with confidence.

If you are attending ELRIG Drug Discovery 2026 and would like to know more about IP, get in touch with us to arrange a meeting.

See you in London at booth D11

Intellectual Property Strategy Checklist

An effective Intellectual Property (IP) strategy is the key to securing a competitive edge. It's a living plan, not a one-time event, and every innovative company needs one. Download and complete your IP Checklist and get in touch with our attorneys to begin.

Download your IP Checklist

ELRIG Series: Managing freedom-to-operate (FTO) risks in drug discovery startups

ELRIG Series: Smart intellectual property (IP) strategies for resource-constrained drug discovery startups

ELRIG Series: Resolving patent ownership issues in drug discovery startups

ELRIG Series: Timing patent filings for maximum impact in drug discovery startups

ELRIG Series: Choosing between patents and trade secrets in early-stage drug development

ELRIG Series: Managing intellectual property (IP) risks in licensing and collaboration agreements

ELRIG Series: Strengthening your intellectual property (IP) position ahead of investor due diligence

Chemistry and Pharmaceuticals

Our clients operate at the forefront of this fast-paced and dynamic sector

Our team has a wealth of experience gained from working with world leaders in the chemistry and pharmaceutical disciplines encompassing new chemical entities, materials science, agricultural chemistry, chemical processes and formulation technology. We have also worked extensively in the medical device materials and carbon nanotechnology sectors.

The team works across all areas of pharmaceuticals, industrial chemistry and medical devices, with experience spanning academic and in-house environments, as well as private practice. Some of our attorneys have gained considerable insight working in industry and being closely involved in the protection and defence of market leading pharmaceuticals.

For intellectual property advice relating to your next project, please get in touch. Our team will be happy to assist.

Secerna LLP at ELRIG Drug Discovery